Today: 7 February 2026
Subscribe

Synopsys stock slips today as SNPS faces lawsuit deadline in thin year-end trade

Synopsys stock slips today as SNPS faces lawsuit deadline in thin year-end trade

NEW YORK, December 30, 2025, 15:44 ET — Regular session Synopsys shares were down $3.06, or 0.6%, at $475.91 in late-afternoon trade, after moving between $472.05 and $483.14 on the day. The chip-design software company sells electronic design automation tools — software used to design and verify semiconductors — and its stock has been sensitive to shifts in AI-linked tech sentiment into year-end. That sensitivity is getting tested on a holiday-thinned session when small headlines can drive outsized moves. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” said Mark Hackett, chief market strategist at
30 December 2025
·
S&P Global (SPGI) stock slips near $529 as Fed minutes, year-end flows keep Wall Street muted

S&P Global (SPGI) stock slips near $529 as Fed minutes, year-end flows keep Wall Street muted

NEW YORK, December 30, 2025, 15:35 ET — Regular session S&P Global Inc shares edged lower on Tuesday as investors weighed a cautious year-end tape and fresh U.S. auto demand projections from the company’s Mobility unit. The stock was down 0.16% at $529.25 in afternoon trading, after moving between $528.24 and $531.97. S&P Global, a key supplier of financial data and benchmarks, operates across credit ratings, market intelligence, commodity data, automotive analytics and index services. That mix leaves the stock closely tied to shifts in capital-markets activity and risk appetite, from corporate bond issuance that drives ratings fees to assets
30 December 2025
··
Why Qualys stock is sliding today: QLYS lags cybersecurity peers in late-year trade

Why Qualys stock is sliding today: QLYS lags cybersecurity peers in late-year trade

NEW YORK, December 30, 2025, 15:41 ET — Regular session Qualys Inc shares fell 2.5% to $133.93 in afternoon trading on Tuesday, after dropping as much as 4.2% earlier in the session. The stock closed at $137.34 on Monday. The decline landed as U.S. equities stayed range-bound in holiday-thin conditions, with technology and financial shares among the drags. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” said Mark Hackett, chief market strategist at Nationwide. Reuters That matters for Qualys because lighter year-end liquidity can exaggerate moves in single names, especially in software stocks where
30 December 2025
··
Terns Pharmaceuticals stock slides today, testing the $40 level after December share sale

Terns Pharmaceuticals stock slides today, testing the $40 level after December share sale

NEW YORK, December 30, 2025, 15:30 ET — Regular session. Shares of Terns Pharmaceuticals, Inc. fell 2.8% to $40.34 in afternoon trading on Tuesday, after swinging between $39.99 and $41.98. The pullback puts the stock back around $40, the price used in the company’s recent upsized equity offering — a level traders often watch after a big deal resets supply and demand. That matters now because Terns’ December financing and trial update put new attention on how quickly the biotech can turn early leukemia data into larger studies, while also giving it a much longer cash runway. Biotech shares were
30 December 2025
··
American Express stock dips today as Fed minutes weigh on financials; AXP earnings date in focus

American Express stock dips today as Fed minutes weigh on financials; AXP earnings date in focus

NEW YORK, December 30, 2025, 15:31 ET — Regular session Key points: American Express Co (AXP) shares fell 0.3% to $374.12 in late afternoon trading on Tuesday, after moving between $373 and $377 in the session. Visa and Mastercard were also down about 0.2% and 0.1%, respectively. The move matters because American Express is one of the higher-priced components of the Dow, a price-weighted index that gives bigger sway to costlier stocks. With year-end liquidity thin, small swings can ripple through benchmarks and sector ETFs more quickly. Investors are also treating AXP as a read-through on rate expectations and consumer
30 December 2025
··
SRRK stock drops 3% today: What’s driving Scholar Rock shares as FDA reinspection nears

SRRK stock drops 3% today: What’s driving Scholar Rock shares as FDA reinspection nears

NEW YORK, December 30, 2025, 15:25 ET — Regular session Scholar Rock Holding Corp (SRRK) slid 3.2% to $43.76 in afternoon trading on Tuesday after opening at $45.18. The stock traded between $45.95 and $43.74. The move matters because Scholar Rock’s near-term valuation still hinges on regulatory timing for apitegromab, its lead drug candidate. he company said in an October update that the FDA classified a third-party manufacturing site in Bloomington, Indiana (formerly Catalent Indiana LLC, now fully owned and operated by Novo Nordisk) as “official action indicated” and that it requested a Type A meeting to discuss resubmitting its
30 December 2025
·
Progressive stock ticks higher today after SEC filing flags 87,755-share gift; what investors watch next

Progressive stock ticks higher today after SEC filing flags 87,755-share gift; what investors watch next

NEW YORK, December 30, 2025, 15:29 ET — Regular session Shares of The Progressive Corporation (NYSE:PGR) were up about 0.7% at $230 on Tuesday afternoon after a regulatory filing disclosed a large gift of stock by a company director. The stock traded between $227.53 and $230.03, with about 1.0 million shares changing hands. The disclosure lands in a year-end market where liquidity is thin and small shifts in positioning can show up quickly in defensive financials such as insurers. Progressive is also heading into a key stretch for the personal auto insurance group, where investors tend to focus on whether
30 December 2025
···
GRAIL stock drops in New York session as Galleri FDA filing timeline returns to focus

GRAIL stock drops in New York session as Galleri FDA filing timeline returns to focus

NEW YORK, December 30, 2025, 15:32 ET — Regular session GRAIL Inc shares were down 3.3% at $84.95 in afternoon trading on Tuesday, after earlier touching $84.77. The early-cancer detection company is trying to turn Galleri — a multi-cancer early detection (MCED) blood test that screens for signals across many cancers from a single draw — into a mainstream part of care. In its most recent quarterly update, Grail said U.S. Galleri revenue rose 28% year-on-year to $32.6 million and test volumes increased 39%, while it anticipated completing a U.S. premarket approval filing in the first quarter of 2026. GRAIL
30 December 2025
··
McDonald’s stock today: MCD edges down as Fed minutes, year-end trade keep investors cautious

McDonald’s stock today: MCD edges down as Fed minutes, year-end trade keep investors cautious

NEW YORK, December 30, 2025, 15:29 ET — Regular session McDonald’s Corp shares edged lower on Tuesday, trading at $308.37, down 0.05% in late-afternoon dealings. The timing matters. With two sessions left in the year, trading volumes tend to thin out, and small shifts in positioning can move stocks more than usual, especially in defensive names investors use to park cash. Portfolio managers also use the final week of December to trim big winners and rebalance exposure for January. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” said Mark Hackett, chief market strategist at
30 December 2025
··
Bloom Energy stock slips today as Clear Street lifts target but keeps Hold in thin year-end trade

Bloom Energy stock slips today as Clear Street lifts target but keeps Hold in thin year-end trade

NEW YORK, December 30, 2025, 15:25 ET — Regular session Bloom Energy Corp shares fell on Tuesday as year-end positioning and a soft tape for growth stocks kept pressure on the fuel-cell maker. The stock was down 1.7% at $86.93 in afternoon trading. The move matters because trading volumes have stayed light in the holiday-truncated week, which can amplify intraday swings in volatile names. U.S. stocks were subdued in choppy trade, with gains in communication services capped by declines in technology and financials, Reuters reported. Reuters Analysts are also recalibrating their assumptions for companies tied to data-center power demand, a
30 December 2025
··
Upwork stock drops 3% today as UPWK slips below $20 with earnings ahead

Upwork stock drops 3% today as UPWK slips below $20 with earnings ahead

NEW YORK, December 30, 2025, 15:28 ET — Regular session Upwork Inc shares were last down 3.4% at $19.60 on Tuesday, after dipping as low as $19.60 in the session. The stock, valued at about $2.46 billion, was sliding even as the S&P 500 and Nasdaq-100 proxies were only modestly lower. The move matters because Upwork has been trading as a profitability-and-execution story, leaving the stock prone to sharp swings when investors rotate away from smaller growth names. A fall below the $20 level also puts a spotlight on near-term technical support, with traders watching whether the stock can reclaim
30 December 2025
··
American Airlines stock edges up today as Chicago O’Hare expansion and storm fallout stay in focus

American Airlines stock edges up today as Chicago O’Hare expansion and storm fallout stay in focus

NEW YORK, December 30, 2025, 15:22 ET — Regular session American Airlines Group Inc shares were up about 0.6% at $15.24 in afternoon trading on Tuesday. The move matters now because U.S. carriers are still working through weather-driven disruption during a peak holiday travel stretch, while also selling spring schedules that can shape early-2026 revenue and costs. Chicago is a key battleground. For American, the O’Hare hub feeds higher-yielding connections and international flying, and changes there can quickly show up in load factors and pricing. American on Monday said it will add 100 peak daily departures from Chicago O’Hare in
30 December 2025
···
Hut 8 stock today: Why HUT is down even as bitcoin edges higher

Hut 8 stock today: Why HUT is down even as bitcoin edges higher

NEW YORK, December 30, 2025, 15:21 ET — Regular session Hut 8 Corp (HUT) shares fell 3.1% to $47.31 in afternoon trading on Tuesday, after moving between $47.18 and $49.26 earlier in the session. About 2.26 million shares had traded. The pullback matters because Hut 8 sits at the intersection of two fast-moving themes: bitcoin-linked equities and the market’s scramble for data centers to run artificial intelligence (AI) workloads. That mix has made the stock prone to sharp, sentiment-driven swings. The broader backdrop has been choppy. U.S. stocks were subdued on Tuesday and trading volumes remained thin in the holiday-truncated
30 December 2025
····
Coca-Cola stock slips as Fed minutes hit thin year-end trade; KO investors eye next catalyst

Coca-Cola stock slips as Fed minutes hit thin year-end trade; KO investors eye next catalyst

NEW YORK, December 30, 2025, 3:25 PM ET — Regular session Coca-Cola shares edged lower on Tuesday, holding near $70 as investors kept risk-taking limited in thin, year-end trading. The quiet tape matters because Coca-Cola is a classic defensive stock. When markets get choppy, investors often rotate into consumer staples — everyday products like food and beverages — for steadier demand and cash returns. It also matters now because interest-rate expectations are back in focus. Dividend-paying shares can lose relative appeal when bond yields rise, since investors can earn more in cash-like alternatives without taking equity risk. Coca-Cola was down
30 December 2025
··
Verizon stock today: VZ edges up as DOJ DEI probe headline hangs over telecom ahead of Jan. 30 earnings

Verizon stock today: VZ edges up as DOJ DEI probe headline hangs over telecom ahead of Jan. 30 earnings

NEW YORK, December 30, 2025, 15:17 ET — Regular session Verizon Communications Inc shares were up 0.5% at $40.69 in afternoon trading on Tuesday, bucking a mostly flat U.S. market as investors digested new regulatory scrutiny and looked ahead to the carrier’s next earnings update. Reuters The latest headline matters because legal and compliance risk can move quickly for large government contractors, and telecoms are already grappling with intense competition and heavy capital spending. Any shift in policy pressure can influence costs, disclosures and management attention. Reuters It also lands during year-end, low-liquidity trading, when relatively small flows can push
30 December 2025
·
TIC Solutions (TIC) stock slides 3.5% today as Fed minutes and thin year-end trade set the tone

TIC Solutions (TIC) stock slides 3.5% today as Fed minutes and thin year-end trade set the tone

NEW YORK, December 30, 2025, 15:14 ET — Regular session Shares of TIC Solutions, Inc. (TIC) fell about 3.5% to $10.02 in afternoon trading on Tuesday, underperforming a largely steady U.S. equity market. The stock last closed at $10.38. The decline came in holiday-thin trade as investors recalibrated rate expectations after the Federal Reserve’s December-meeting minutes hit the tape. “At the end of the day, solid corporate profits can make up for a lot of sins,” said Ryan Detrick, chief market strategist at Carson Group. Reuters The slide matters for TIC because investors have been focused on execution rather than
30 December 2025
··
Applied Materials stock slips as China’s 50% domestic chip-tool rule puts AMAT in the spotlight

Applied Materials stock slips as China’s 50% domestic chip-tool rule puts AMAT in the spotlight

NEW YORK, December 30, 2025, 15:20 ET — Regular session Applied Materials, Inc. (AMAT.O) shares slipped on Tuesday, with investors weighing fresh signs of tougher competition in China for semiconductor equipment makers. The stock was down 1.1% at $260.27 in mid-afternoon New York trade. The stock drew attention after Reuters reported China is requiring chipmakers seeking approval to build or expand fabs to use at least 50% domestically made equipment when adding new capacity. The measure is not publicly documented and is enforced through procurement tenders, people familiar with the matter told Reuters, and authorities can relax the threshold where
30 December 2025
·····
Why Travere Therapeutics (TVTX) stock is down today as insider sales hit the tape ahead of a key FDA date

Why Travere Therapeutics (TVTX) stock is down today as insider sales hit the tape ahead of a key FDA date

NEW YORK, December 30, 2025, 15:16 ET — Regular session Travere Therapeutics Inc shares were down about 3.8% at $37.39 on Tuesday afternoon, extending losses after recent insider-trading disclosures. The stock traded between $37.27 and $39.20, with about 893,000 shares changing hands. (TVTX quote) The selling matters because it lands just weeks before a major regulatory milestone for the rare-disease drugmaker. Traders often react to clusters of insider sales — even when they are planned — as they reassess near-term positioning. Travere, based in San Diego, markets Filspari for a kidney disease called IgA nephropathy, and is seeking an expansion
30 December 2025
Qualcomm stock edges up as Fed minutes hit; QCOM eyes Feb. 4 earnings call

Qualcomm stock edges up as Fed minutes hit; QCOM eyes Feb. 4 earnings call

NEW YORK, December 30, 2025, 15:14 ET — Regular session Qualcomm (QCOM.O) shares were up about 0.2% at $173.75 in afternoon trading on Tuesday, hovering near Monday’s close as markets digested new details on the U.S. interest-rate outlook. That matters for Qualcomm and other semiconductor names because investors often value them like “growth” stocks, whose prices can swing when bond yields move. In year-end trading, the rate narrative can outweigh company-specific headlines. Minutes from the Federal Reserve’s Dec. 9-10 meeting — the detailed account of policymakers’ debate — showed officials split even after approving a quarter-point, or 0.25 percentage point,
30 December 2025
····
Catalyst Pharmaceuticals stock drops 3% today as CPRX lags biotech in thin year-end trade

Catalyst Pharmaceuticals stock drops 3% today as CPRX lags biotech in thin year-end trade

NEW YORK, December 30, 2025, 2:30 PM ET — Regular session Shares of Catalyst Pharmaceuticals, Inc. fell 3.0% to $23.33 in afternoon trading on Tuesday. The stock has traded between $23.30 and $24.10 so far in the session. The drop matters because trading can get choppy in the final days of the year, when fewer investors are active and price moves can be exaggerated. Mid-cap healthcare names often swing more than the major indexes in that setting. Catalyst fell 1.2% on Monday to close at $24.06, according to MarketWatch data, and it remains well below its June 9 52-week high
30 December 2025
··
1 … 652 653 654 655 656 … 1,632

Stock Market Today

ASML stock price snaps back as AI spending bets return, with ex-dividend date next

ASML stock price snaps back as AI spending bets return, with ex-dividend date next

7 February 2026
ASML shares rose 3.84% Friday in Amsterdam to 1,193.80 euros, rebounding with global chip stocks after Amazon signaled a sharp increase in AI-related capital spending. The stock goes ex-dividend Feb. 9 ahead of a 1.60-euro interim payout. ASML’s Nasdaq shares climbed 4.64% to $1,413.01. Despite Friday’s gains, the Amsterdam listing finished the week about 2.5% lower.
Mastercard stock price: MA slips as Dow hits 50,000; jobs and CPI data next week

Mastercard stock price: MA slips as Dow hits 50,000; jobs and CPI data next week

7 February 2026
Mastercard shares closed down 0.6% at $548.74 Friday, trailing gains in Visa and American Express. The Dow Jones Industrial Average surged 2.47% to a record 50,115.67. Mastercard disclosed a new cybersecurity partnership in the UAE and raised compensation for two top executives. U.S. jobs and inflation data, delayed by a government shutdown, are due next week.
Costco stock price retakes $1,000 — what traders are watching before Monday

Costco stock price retakes $1,000 — what traders are watching before Monday

7 February 2026
Costco closed Friday up 1.2% at $1,001.16, regaining the $1,000 level as about 2.36 million shares changed hands. January net sales rose 9.3% to $21.33 billion, with comparable sales up 7.1% and online sales surging 34.4%. Wells Fargo raised its price target to $950, maintaining a neutral rating. The next earnings call is set for March 5.
Go toTop